Management of Back Pain in Crohn's Disease

Introduction to Back Pain Management

• The American Gastroenterological Association recommends acetaminophen as the first-line analgesic for mild to moderate back pain in Crohn's disease patients due to its favorable safety profile and lack of gastrointestinal toxicity 1
• The use of NSAIDs should be avoided in Crohn's disease patients as they can precipitate new IBD activity or exacerbate pre-existing disease, according to the European Crohn's and Colitis Organisation 3, 1

NSAIDs: Use Only With Extreme Caution

• The American College of Gastroenterology recommends that NSAIDs should only be used in Crohn's disease patients if the disease is in documented remission, and only for short-term use (less than 2 weeks maximum) 2, 4
• The lowest effective dose of NSAIDs should be used, as recommended by the American Gastroenterological Association 2

If Back Pain is From Spondyloarthropathy (IBD-Related)

• The European League Against Rheumatism recommends anti-TNF therapy as the preferred treatment for axial spondyloarthropathy associated with Crohn's disease, rather than NSAIDs 2, 3
• Joint management with rheumatology is mandatory, and intensive physiotherapy should be used as foundational therapy, according to the American College of Rheumatology 2, 3

Adjuvant Pain Management Options

• The American Pain Society recommends tricyclic antidepressants (e.g., low-dose amitriptyline 10-25mg at bedtime) as adjuvant analgesics for chronic back pain, particularly when pain persists despite disease control 1, 5
• The American Gastroenterological Association recommends avoiding long-term opioids, as they are associated with increased mortality, serious infections, and poor outcomes in IBD patients 6

Critical Pitfall to Avoid

• The European Crohn's and Colitis Organisation recommends never assuming back pain is mechanical without investigating for IBD-related spondyloarthropathy, as up to 20% of IBD patients develop sacroiliitis or spondylitis 2